Chief Risk Officer for Swiss Re Life & Health America

Providing actuarial services to life insurance and reinsurance companies with a special emphasis on regulatory changes, financial reporting, and applied data science.

General Assembly’s Data Science Immersive (DSI) is a 12-week long training program dedicated to give students a deep dive into the world of Data Science, focusing on the ability to analyze, make sense of, convey data-driven facts from massive data sets, and predict what happens next through predictive modeling and pattern recognition. (Also consider profiling projects and skills here: Data Science, Python, SQL, Machine Learning, Tableau, Git/Github, Data Mining, Research, etc.)

Reorganized the business operating model in a short time frame so that the company could continue to operate in a capital and reserve efficient manner after the passage of the US Tax Cuts and Jobs Act of 2017, saving the company $300m of additional taxes per year.Opened a new life insurance company in Bermuda as a sister company to the US life insurance operations of Munich Re. Transferred the majority of the company's internal retrocessions to this company.Implemented a capital monitoring tax force in 2016 to more intently monitor, predict, and react to changes in the local operating company's regulatory required capital position.Oversaw the pricing and accounting of the divesture of Life Plans, Inc, a long term care and health insurance service company.

Lead three departments over this twelve year period: Corporate Actuarial, Strategic Risk Management, and North American Risk Management. Served as appointed actuary from 2004 - 2009 and 2017. Designed and implemented successful ORSA compliance for the US and Canadian entities. Moved the company's statutory reserve methodology from a "reported by client" model to a self-calculation model. This strengthened controls around statutory reporting and significantly reduced the risk of potential financial reporting errors.Engineered the balance sheet, through internal retrocession, to significantly reduce required capital for the US entities.Over time, implemented XXX reserve financing strategies which enabled the company to continue writing level term business. First, a letter of credit approach was used which reduced the cash strain of the business by $500m. Later, implemented a limited purpose subsidiary construct which enabled a return of over $1b in assets to the home office.Was active in lobbying efforts in conjunction with MARC's Chief Legal Counsel, the ACLI, and RAA. Successful efforts include provisions in the Dodd-Frank Act and the NAIC's principles based reserve system. Lead due diligence and transaction pricing on three major transactions/block purchases.

Served as the appointed actuary of two legal entities, including a New York domiciled company.

Assisted international companies seeking to list on the New York Stock Exchange with conversion of their financial statements to a US GAAP basis.Worked with client companies to determine and then frame lobbying positions for the emerging International Financial Reporting Standards (IFRS). Supported audit teams with respect to reviews of actuarial assets and liabilities.Helped companies remediate errors with respect IRS code section 7702 and 7702A.

Performed cash flow testing calculations in TAS. Valued the company's self-insured LTD plan.Converted the asset share pricing system to an APL based calculation with the ability to perform 100s of sensitivity runs in the time it previously took to run a base calculation.